The EVAR Center

Filter Your Results

 

News

 

Three-Year IMPROVE Results Compare Treatment Strategies for Ruptured AAA

November 16, 2017 -- Three-year results from the IMPROVE trial comparing strategies to treat ruptured abdominal aortic aneurysms (rAAAs) were published online in BMJ by Profes…

Occurrence and Classification of Proximal Endoleaks Studied for the Nellix EVAS Device

November 15, 2017 -- Leo H. van den Ham, MD, et al published findings from a study that aimed to analyze and categorize proximal endoleaks in a cohort of patients treated with…

Study Detects Radiation-Induced DNA Damage in Operators Performing EVAR

November 8, 2017 -- A study that aimed to measure DNA damage/repair markers in operators performing endovascular aneurysm repair (EVAR) was published by Tamer El-Sayed, MD, et…

SVS Announces Study Supporting Fully Percutaneous Approach for Repair of Ruptured AAA

November 2, 2017 -- The Society for Vascular Surgery (SVS) announced that findings from a comparison of percutaneous access versus femoral cutdown during endovascular repair o…

Twelve-Year Data Reported From DREAM Trial Comparing EVAR and Open Repair of AAAs

October 25, 2017 -- Theodorus G. van Schaik, MD, et al published findings updating the results of the Dutch Randomized Endovascular Aneurysm Management (DREAM) trial in Journa…

Study Shows Black Patients Present With More Advanced Disease at Time of Initial Major Vascular Interventions

October 18, 2017 -- In Journal of Vascular Surgery (JVS), Peter A. Soden, MD, et al published findings online ahead of print from a study that aimed to evaluate differences in…

Kawasumi’s Najuta Thoracic Stent Graft Receives CE Mark Approval for TEVAR

October 17, 2017 -- Kawasumi Laboratories, Inc. announced European CE Mark approval in July for the Najuta thoracic stent graft system, which is indicated for thoracic endovas…

First Patient Enrolled in Vivasure’s Frontier IV Clinical Trial

October 13, 2017 -- Vivasure Medical announced that the first patient was enrolled in the Frontier IV clinical study, a nonrandomized, multicenter trial designed to expand the…

 

advertisement

2017 Device Guide

This Device Guide offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.